CTNM vs FSLR · $429.6M cap vs P/E 16, rev $2.10B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus First Solar Inc (FSLR) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
First Solar Inc (FSLR) is a solar company listed on NASDAQ. It is led by Mark R. Widmar.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported FSLR revenue for 2026-06-30 was $2.10B. Net income was $769.2M. FSLR currently screens at market cap $27.38B and trailing P/E 16.4.
CTNM currently screens at market cap $429.6M. FSLR currently screens at market cap $27.38B and trailing P/E 16.4.
Not investment advice. Open the CTNM and FSLR stock pages for the full models.
Not investment advice.